| 基于最新诊疗方案中抗新型冠状病毒药物的回顾分析与药学监护 |
| |
| 引用本文： | 车坷科,刘雪梅,胡昌华.基于最新诊疗方案中抗新型冠状病毒药物的回顾分析与药学监护[J].西南农业大学学报,2020,42(3):1-9. |
| |
| 作者姓名： | 车坷科 刘雪梅 胡昌华 |
| |
| 作者单位： | 1. 西南大学 药学院/医学研究院转化药学研究中心, 重庆 400715;2. 中国科学院大学 重庆医院/重庆市人民医院 药学部, 重庆 400014 |
| |
| 基金项目： | 重庆市新型冠状病毒感染肺炎疫情应急科技攻关专项（cstc2020jscx-fyzx0135）. |
| |
| 摘 要： | 2019年12月以来,湖北武汉爆发由新型冠状病毒引发的病毒性肺炎疫情并迅速蔓延,现已确认该新型病毒为SARS-CoV-2.由于目前针对该病毒尚无确切有效的抗病毒药物,给我国公共卫生事业带来了严峻的考验.随着疫情的发展,国家卫生健康委员会下发了最新的《新型冠状病毒肺炎诊疗的方案(试行第七版)》.该文从临床药学角度对最新诊疗方案中所涉及的抗病毒药物进行回顾分析,提出药学监护的重点,并对潜在有效的药物进行展望,以期为抗击新型冠状病毒疫情提供药物使用参考.
|
| 关 键 词： | 新型冠状病毒 新型冠状病毒肺炎 抗病毒药物 药学监护 |
| 收稿时间： | 2020/3/3 0:00:00 |
Antiviral Drugs Based on the Latest Diagnosin and Treatment Guidelines for COVID-2019 |
| |
| CHE Ke-ke,LIU Xue-mei,HU Chang-hua.Antiviral Drugs Based on the Latest Diagnosin and Treatment Guidelines for COVID-2019[J].Journal of Southwest Agricultural University,2020,42(3):1-9. |
| |
| Authors: | CHE Ke-ke LIU Xue-mei HU Chang-hua |
| |
| Institution: | 1. College of Pharmaceutical Sciences/Center of Translational Pharmacy of Medical Research Institute, Southwest University, Chongqing 400715, China;2. Chongqing General Hospital, University of Chinese Academy of Sciences/Department of Pharmacology, Chongqing People''s Hospital, Chongqing 400014, China |
| |
| Abstract: | Since the outbreak of 2019-nCoV (2019 novel coronavirus infection) in Wuhan, China in December, 2019, the virus has spread rapidly. The new virus has been identified as SARS-CoV-2. As there is no effective antiviral drug for SARS-CoV-2 at present, it has brought serious harm to China''s public health security and social development. With the development of the epidemic, the National Health Commission of People''s Republic of China has issued an updated Guidelines on the Novel Coronavirus-Infected Pneumonia Diagnosis and Treatment (Trial Version 7). This article reviews the antiviral drugs involved in the latest diagnosis and treatment program from the perspective of clinical pharmacology, suggests the focus of pharmaceutical care, and discuss potentially effective drugs so as to provide a reference for the majority of medical workers who fight novel coronavirus infection in diagnosis and treatment. |
| |
| Keywords: | novel coronavrius(2019-nCoV) novel coronavirus pneumonia antiviral drug pharmaceutical care |
| 本文献已被 CNKI 等数据库收录！ |
| 点击此处可从《西南农业大学学报》浏览原始摘要信息 |
| 点击此处可从《西南农业大学学报》下载免费的PDF全文 |
|
